2019
DOI: 10.1177/1535370219877360
|View full text |Cite
|
Sign up to set email alerts
|

17β-estradiol alters mRNA co-expression after murine muscle injury and mild hypobaria

Abstract: Here, we assessed the effects of 17β-estradiol exposure on mRNA co-expression patterns of muscle tissue during recovery in a closed muscle crush injury and hypobaria exposure murine model. Eighteen ovariectomized placebo-treated and 18 ovariectomized 17β-estradiol-treated female mice underwent closed muscle crush injury and hypobaric simulated flight. The mice recovered for 32, 96, or 192 h, and then were euthanized. Their harvested injured lateral gastrocnemius muscles underwent microarray analysis. We used w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 60 publications
(102 reference statements)
0
3
2
Order By: Relevance
“…Based on additional evidence showing the anti-inflammatory and symptom-reducing properties of estrogen in both injury-related studies and menopausal studies, as well as studies in other chronic illness populations, we hypothesized that higher LdEE would be associated with reduced symptom distress. This relationship was not observed in our study sample (Hardman & Ashcroft, 2008; Moore et al, 2019; Mul et al, 2018; Oughli et al, 2021). We believe that this may be related to several potential factors: (a) different patterns of exogenous estrogen usage among WWH, (b) the limited number of individuals in the sample found to be premenopausal with low ovarian reserve, (c) broad variability of the frequency of pregnancies among the study sample, and (4) cross-sectional design only capturing symptoms from the 4 weeks before completion of the PROs.…”
Section: Discussioncontrasting
confidence: 74%
See 1 more Smart Citation
“…Based on additional evidence showing the anti-inflammatory and symptom-reducing properties of estrogen in both injury-related studies and menopausal studies, as well as studies in other chronic illness populations, we hypothesized that higher LdEE would be associated with reduced symptom distress. This relationship was not observed in our study sample (Hardman & Ashcroft, 2008; Moore et al, 2019; Mul et al, 2018; Oughli et al, 2021). We believe that this may be related to several potential factors: (a) different patterns of exogenous estrogen usage among WWH, (b) the limited number of individuals in the sample found to be premenopausal with low ovarian reserve, (c) broad variability of the frequency of pregnancies among the study sample, and (4) cross-sectional design only capturing symptoms from the 4 weeks before completion of the PROs.…”
Section: Discussioncontrasting
confidence: 74%
“…Based on additional evidence showing the antiinflammatory and symptom-reducing properties of estrogen in both injury-related studies and menopausal studies, as well as studies in other chronic illness populations, we hypothesized that higher LdEE would be associated with reduced symptom distress. This relationship was not observed in our study sample (Hardman & Ashcroft, 2008;Moore et al, 2019;Mul et al, 2018;Oughli et al, 2021). We believe that this may be related to Copyright © 2024 Association of Nurses in AIDS Care.…”
Section: Discussioncontrasting
confidence: 56%
“…Only females were evaluated. As estrogen influences gene expression after a crush muscle injury and HB exposure (Moore et al, 2019), these findings may not be generalizable to males. Future investigations involving male mice are needed.…”
Section: Discussionmentioning
confidence: 99%
“…RNA isolation and preparation procedures were described by Moore et al (2019). At the University of Washington Department of Environmental & Occupational Health Sciences microarray facility, the samples underwent the Affymetrix GeneChip Whole Transcript Sense target labeling protocol for the Affymetrix Mouse Gene 1.0 ST array (Santa Clara, CA).…”
Section: Microarray Assaymentioning
confidence: 99%
See 1 more Smart Citation